Additional file 1 of Stepped implementation-to-target: a study protocol of an adaptive trial to expand access to addiction medications

Autor: Ford, James H., Cheng, Hannah, Gassman, Michele, Fontaine, Harrison, Garneau, Hélène Chokron, Keith, Ryan, Michael, Edward, McGovern, Mark P.

Additional file 1. The Standards for Reporting Implementation Studies (StaRI) reporting standards and checklist.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41988745e61423c03ce63c4db5aa5de8

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Stress decreases serotonin tone in the nucleus accumbens in male mice to promote aversion and potentiate cocaine preference via decreased stimulation of 5-HT 1B receptors.

Autor: Fontaine HM; Department of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.; Center for the Neurobiology of Addiction, Pain, and Emotion, University of Washington School of Medicine, Seattle, WA, 98195, USA., Silva PR; Center for the Neurobiology of Addiction, Pain, and Emotion, University of Washington School of Medicine, Seattle, WA, 98195, USA.; Graduate Program in Neuroscience, University of Washington School of Medicine, Seattle, WA, 98195, USA.; Puget Sound VA Health Care System, Seattle, WA, 98108, USA., Neiswanger C; Department of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.; Center for the Neurobiology of Addiction, Pain, and Emotion, University of Washington School of Medicine, Seattle, WA, 98195, USA., Tran R; Department of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.; Center for the Neurobiology of Addiction, Pain, and Emotion, University of Washington School of Medicine, Seattle, WA, 98195, USA., Abraham AD; Department of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.; Center for the Neurobiology of Addiction, Pain, and Emotion, University of Washington School of Medicine, Seattle, WA, 98195, USA., Land BB; Department of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.; Center for the Neurobiology of Addiction, Pain, and Emotion, University of Washington School of Medicine, Seattle, WA, 98195, USA., Neumaier JF; Department of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA.; Center for the Neurobiology of Addiction, Pain, and Emotion, University of Washington School of Medicine, Seattle, WA, 98195, USA.; Puget Sound VA Health Care System, Seattle, WA, 98108, USA.; Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, 98195, USA., Chavkin C; Department of Pharmacology, University of Washington School of Medicine, Seattle, WA, 98195, USA. cchavkin@uw.edu.; Center for the Neurobiology of Addiction, Pain, and Emotion, University of Washington School of Medicine, Seattle, WA, 98195, USA. cchavkin@uw.edu.

Publikováno v: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2022 Mar; Vol. 47 (4), pp. 891-901. Date of Electronic Publication: 2021 Sep 25.